# Throne Biotechnologies Inc. — Form C (Regulation Crowdfunding)

Throne Biotechnologies Inc. of Paramus, NJ filed a Form C (Regulation Crowdfunding) with the SEC on 2022-02-25. Target raise $10K, up to $1.0M. Offered through StartEngine Capital, LLC.

## Offering

- Filed: 2022-02-25
- Form: C
- Accession: 0001665160-22-000346
- Target amount: $10K
- Maximum amount: $1.0M
- Security type: Common Stock
- Securities offered: 1,317
- Price: $7.5900
- Deadline: 2022-04-30
- Funding portal / intermediary: StartEngine Capital, LLC
- Intermediary file number: 007-00007

## Issuer

- CIK: 0001912674
- Website: thronebio.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2011-01-19
- Address: 10 Forest Avenue, Suite 110, Paramus, NJ, 07652
- Employees: 5

## Financials (as filed)

- Total assets (most recent): $2.2M
- Cash (most recent): $60K
- Net income (most recent): $-482K
- Net income (prior): $-497K
- Short-term debt: $360K
- Long-term debt: $409K

## People (2)

| Name | Role | Location |
| --- | --- | --- |
| Yong Zhao | CEO and Director | New York, NY |
| Lee Dudka | Director | Paramus, NJ |

## More

- [CIK 1912674 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1912674&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001665160-22-000346.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.